Physician profile
Alison B Eeten
NPI 1710138508
$864.04
in general payments reported to CMS, 2019-2025
14 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $112 · 2023: $168 · 2024: $116 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $251.59 | 2021-2023 | |
| Astellas Pharma US INC | $135.12 | 2022-2025 | Veozah |
| Biogen, INC. | $89.10 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $62.17 | 2022-2025 | Slynd |
| Pfizer INC. | $60.64 | 2021-2023 | |
| Agile Therapeutics, INC. | $44.17 | 2021-2024 | Twirla |
| Daiichi Sankyo INC. | $43.08 | 2021 | |
| Sumitomo Pharma America, INC. | $40.35 | 2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $36.48 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.34 | 2025 | |
| Mayne Pharma Commercial LLC | $24.09 | 2025 | |
| Hologic Sales and Service, LLC | $21.75 | 2024 | Aptima |
| Evofem Biosciences, INC. | $12.29 | 2022 | |
| Dysis Medical, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Eeten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.